Article
AI-Based Discovery and CryoEM Structural Elucidation of a K <sub>ATP</sub> Channel Pharmacochaperone
2024-09-05
Abstract excerpt
Pancreatic K ATP channel trafficking defects underlie congenital hyperinsulinism (CHI) cases unresponsive to the K ATP channel opener diazoxide, the mainstay medical therapy for CHI. Current clinically used K ATP channel inhibitors have been shown to act as pharmacochaperones and restore surface expression of trafficking mutants; however, their therapeutic utility for K ATP trafficking impaired CHI is hindered...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- f617689f-1568-5183-ab1b-62d191c990f8
- DOI
- 10.1101/2024.09.05.611490
